Stock CBIO CATALYST BIOSCIENCES
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Catalyst Biosciences

Equities

CBIO

US14888D2080

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
14.1 USD +1.73% Intraday chart for Catalyst Biosciences -13.66% +83.85%
2023 Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index CI
2023 Beijing Continent Pharmaceutical Co., Ltd. completed the acquisition of Catalyst Biosciences, Inc. in a reverse merger transaction. CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Piper Sandler Adjusts Price Target on Catalyst Biosciences to $4 From $16, Reiterates Overweight Rating
MT
JonesTrading Downgrades Catalyst Biosciences to Hold From Buy
MT
Raymond James Downgrades Catalyst Biosciences to Market Perform From Outperform
MT
CATALYST BIOSCIENCES : Piper Sandler Starts Catalyst Biosciences at Overweight With $15 Price Target
MT
CATALYST BIOSCIENCES : Raymond James Adjusts Price Target on Catalyst Biosciences to $18 From $20, Keeps Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CBIO Stock
  4. News Catalyst Biosciences
  5. Analyst Reco.